URGN Hisse Senedi Fiyat Grafiği
URGN Hisse Fiyat Tahmini
Urogen Pharma Ltd
$33.57
2.31%
$0.75
Kapanışta: Jun 18, 16:00:00 GMT-4
$33.57
0%
$0
Ön Piyasa: Jun 22, 06:55:50 GMT-4
Geri
Urogen Pharma Ltd (URGN) Hisse Fiyat Tahmini
Önemli İstatistikler
Önceki Kapanış
$32.81
Açılış fiyatı
$33.37
Günün Aralığı
$32.21 - $33.79
52 haftalık aralık
$12.61 - $33.57
İşlem hacmi
847.0K
Ort.Hacim
810.2K
Dividend yield
--
EPS (TTM)
-2.75
Piyasa Değeri
$1.6B
URGN nedir?
UroGen Pharma Ltd. is a biopharmaceutical company, which engages in developing and commercializing innovative solutions that treat urothelial and specialty cancers. The firm is engaged in building solutions for cancers and urologic diseases. UroGen has developed RTGelTM reverse-thermal hydrogel, a proprietary sustained release, hydrogel-based platform technology that has the potential to improve therapeutic profiles of existing drugs. Its lead product candidates include MitoGel and VesiGel are formulated using its proprietary reverse thermally triggered hydrogel, or RTGel, technology. MiroGel ( UGN-101) is a sustained release formulation of the chemotherapy agent Mitomycin C for the treatment of low-grade upper tract urothelial carcinoma, an urothelial cancer in the upper tract. VesiGel (UGN-102) is a sustained release formulation of a high dose Mitomycin C for the treatment of low grade non-muscle invasive bladder cancer (LG-NMIBC).
